Effect of the duration of hospice and palliative care on the quality of dying and death in patients with terminal cancer: A nationwide multicentre study
J.Y. Choi PhD
Senior Scientist
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorK.A. Kong MD, PhD
Professor
Department of Preventive Medicine, College of Medicine, Ewha Womans University, Seoul, South Korea
Search for more papers by this authorY.J. Chang MD, PhD
Senior Scientist, Doctor
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorH.J. Jho MD
Doctor
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorE.M. Ahn MD
Assistant Scientist
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorS.K. Choi MPH
Researcher
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorS. Park MPH
Researcher
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorCorresponding Author
M.K. Lee RN, PhD
Assistant Professor
College of Nursing, Research Institute of Nursing Science, Kyungpook National University, Daegu, South Korea
Correspondence
Myung Kyung Lee, College of Nursing, Research Institute of Nursing Science, Kyungpook National University, Daegu, South Korea.
Email: [email protected]
Search for more papers by this authorJ.Y. Choi PhD
Senior Scientist
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorK.A. Kong MD, PhD
Professor
Department of Preventive Medicine, College of Medicine, Ewha Womans University, Seoul, South Korea
Search for more papers by this authorY.J. Chang MD, PhD
Senior Scientist, Doctor
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorH.J. Jho MD
Doctor
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorE.M. Ahn MD
Assistant Scientist
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorS.K. Choi MPH
Researcher
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorS. Park MPH
Researcher
Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea
Search for more papers by this authorCorresponding Author
M.K. Lee RN, PhD
Assistant Professor
College of Nursing, Research Institute of Nursing Science, Kyungpook National University, Daegu, South Korea
Correspondence
Myung Kyung Lee, College of Nursing, Research Institute of Nursing Science, Kyungpook National University, Daegu, South Korea.
Email: [email protected]
Search for more papers by this authorAbstract
Early referral to hospice and palliative care (HPC) has significant benefits, but little is known about the appropriate time for referral. The purpose of this study of terminal cancer patients was to identify the most appropriate time for referral to HPC. Cross-sectional correlation study design was used. Participants were the bereaved relatives, who were the adult primary caregivers of the 1,829 terminal cancer patients who died 2–6 months previously in nationwide centres that provide HPC in Korea. A post-bereavement survey (Good Death Inventory, GDI) of family caregivers was used to assess patients' quality of dying and death. Relative to patients who were in HPC for 3–7 days and HPC for 8–21 days, those in HPC for 22–84 days had significantly higher quality of dying. Propensity score matched comparison between the group hospitalised for 22–84 days (n = 65) and the group hospitalised for 85 days or longer (n = 65) showed no significant differences in all the items on quality of dying and death. Our results suggest that terminal cancer patients who stay in HPC at least for 22 days have improved quality of dying and death.
REFERENCES
- Browall, M., Henoch, I., Melin-Johansson, C., Strang, S., & Danielson, E. (2014). Existential encounters: Nurses' descriptions of critical incidents in end-of-life cancer care. European Journal of Oncology Nursing, 18(6), 636–644.
- Chen, C., Wang, S., Li, L., Wang, P., Chen, C., Sun, Z., & Song, T. (2016). Bacterial magnetic nanoparticles for photothermal therapy of cancer under the guidance of MRI. Biomaterials, 104, 352–360.
- Chen, X. Z., Yang, K., Liu, J., Chen, X. L., & Hu, J. K. (2011). Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World Journal of Gastroenterology, 17(40), 4542–4544.
- Chochinov, H. M., Hassard, T., McClement, S., Hack, T., Kristjanson, L. J., Harlos, M., … Murray, A. (2009). The landscape of distress in the terminally ill. Journal of Pain and Symptom Management, 38(5), 641–649.
- Clayton, M. F., Reblin, M., Carlisle, M., & Ellington, L. (2014). Communication behaviors and patient and caregiver emotional concerns: A description of home hospice communication. Oncology Nursing Forum, 41(3), 311–321.
- Cohen, S. R., & Mount, B. M. (1992). Quality of life in terminal illness: Defining and measuring subjective well-being in the dying. Journal of Palliative Care, 8(3), 40–45.
- Das, A., Adak, A. K., Ponnapalli, K., Lin, C. H., Hsu, K. C., Yang, J. M., … Lin, C. C. (2016). Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors. European Journal of Medicinal Chemistry, 123, 397–406.
- Davidoff, A. J., Tang, M., Seal, B., & Edelman, M. J. (2010). Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology, 28(13), 2191–2197.
- Diamond, E. L., Russell, D., Kryza-Lacombe, M., Bowles, K. H., Applebaum, A. J., Dennis, J., … Prigerson, H. G. (2016). Rates and risks for late referral to hospice in patients with primary malignant brain tumors. Neuro Oncology, 18(1), 78–86.
- Donnelly, S., Walsh, D., & Rybicki, L. (1995). The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity. Journal of Palliative Care, 11(1), 27–32.
- Elsayem, A., Swint, K., Fisch, M. J., Palmer, J. L., Reddy, S., Walker, P., … Bruera, E. (2004). Palliative care inpatient service in a comprehensive cancer center: Clinical and financial outcomes. Journal of Clinical Oncology, 22(10), 2008–2014.
- Fadul, N. A., El Osta, B., Dalal, S., Poulter, V. A., & Bruera, E. (2008). Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. Journal of Palliative Medicine, 11(3), 422–427.
- Ferrell, B., Levy, M. H., & Paice, J. (2008). Managing pain from advanced cancer in the palliative care setting. Clinical Journal of Oncology Nursing, 12(4), 575–581.
- Follwell, M., Burman, D., Le, L. W., Wakimoto, K., Seccareccia, D., Bryson, J., … Zimmermann, C. (2009). Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. Journal of Clinical Oncology, 27(2), 206–213.
- Greer, J. A., Jackson, V. A., Meier, D. E., & Temel, J. S. (2013). Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA: A Cancer Journal for Clinicians, 63(5), 349–363.
- Greer, J. A., Pirl, W. F., Jackson, V. A., Muzikansky, A., Lennes, I. T., Heist, R. S., … Temel, J. S. (2012). Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. Journal of Clinical Oncology, 30(4), 394–400.
- Hearn, J., & Higginson, I. J. (1997). Outcome measures in palliative care for advanced cancer patients: A review. Journal of Public Health Medicine, 19(2), 193–199.
- Heedman, P. A., & Strang, P. (2001). Symptom assessment in advanced palliative home care for cancer patients using the ESAS: Clinical aspects. Anticancer Research, 21(6a), 4077–4082.
- Hoare, S., Morris, Z. S., Kelly, M. P., Kuhn, I., & Barclay, S. (2015). Do patients want to die at home? A systematic review of the UK literature, focused on missing preferences for place of death. PLoS ONE, 10(11), e0142723.
- Hong, J. H., Kwon, J. H., Kim, I. K., Ko, J. H., Kang, Y. J., & Kim, H. K. (2016). Adopting advance directives reinforces patient participation in end-of-life care discussion. Cancer Research and Treatment, 48(2), 753–758.
- Jenkins, C. A., Schulz, M., Hanson, J., & Bruera, E. (2000). Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital. Journal of Pain and Symptom Management, 19(3), 174–184.
- Johnston, B., & Smith, L. N. (2006). Nurses' and patients' perceptions of expert palliative nursing care. Journal of Advanced Nursing, 54(6), 700–709.
- Kaasa, S., & Loge, J. H. (2003). Quality of life in palliative care: Principles and practice. Palliative Medicine, 17(1), 11–20.
- Karlsson, M., Friberg, F., Wallengren, C., & Ohlen, J. (2014). Meanings of existential uncertainty and certainty for people diagnosed with cancer and receiving palliative treatment: A life-world phenomenological study. BMC Palliat Care, 13, 28.
- Kubler-Ross, E., Wessler, S., & Avioli, L. V. (1972). On death and dying. JAMA, 221(2), 174–179.
- Lee, Y. J., Yang, J. H., Lee, J. W., Yoon, J., Nah, J. R., Choi, W. S., & Kim, C. M. (2015). Association between the duration of palliative care service and survival in terminal cancer patients. Supportive Care in Cancer, 23(4), 1057–1062.
- Lowery, W. J., Lowery, A. W., Barnett, J. C., Lopez-Acevedo, M., Lee, P. S., Secord, A. A., & Havrilesky, L. (2013). Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. Gynecologic Oncology, 130(3), 426–430.
- Matsuo, M., Iwanaga, M., Kondo, H., Soda, M., Jo, T., Horio, K., … Miyazaki, Y. (2016). Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki. Cancer Science, 107(10), 1484–1491.
- McCarthy, E. P., Burns, R. B., Davis, R. B., & Phillips, R. S. (2003). Barriers to hospice care among older patients dying with lung and colorectal cancer. Journal of Clinical Oncology, 21(4), 728–735.
- Miyashita, M., Morita, T., Sato, K., Hirai, K., Shima, Y., & Uchitomi, Y. (2008). Good death inventory: A measure for evaluating good death from the bereaved family member's perspective. Journal of Pain and Symptom Management, 35(5), 486–498.
- Mok, E., & Chiu, P. C. (2004). Nurse-patient relationships in palliative care. Journal of Advanced Nursing, 48(5), 475–483.
- National Cancer Center. (2017). Cancer Facts & Figures 2017 in the Republic of Korea. National Cancer Center, Ministry of Health & Welfare, Republic of Korea, available at: http://www.cancer.go.kr/ebook/208/webview/index.html
- Ranstam, J. (2016). Multiple P-values and Bonferroni correction. Osteoarthritis Cartilage, 24(5), 763–764.
- Riechelmann, R. P., Krzyzanowska, M. K., O'Carroll, A., & Zimmermann, C. (2007). Symptom and medication profiles among cancer patients attending a palliative care clinic. Supportive Care in Cancer, 15(12), 1407–1412.
- Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70, 41–55.
- Rubin, D. B. (2001). Using propensity scores to help design observational studies: Application to the tobacco litigation. Health Services and Outcomes Research Methodology, 2(3), 169–188.
10.1023/A:1020363010465 Google Scholar
- Saito, A. M., Landrum, M. B., Neville, B. A., Ayanian, J. Z., & Earle, C. C. (2011). The effect on survival of continuing chemotherapy to near death. BMC Palliat Care, 10, 14.
- Seow, H., Barbera, L., Sutradhar, R., Howell, D., Dudgeon, D., Atzema, C., … Earle, C. (2011). Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. Journal of Clinical Oncology, 29(9), 1151–1158.
- Shin, D. W., Choi, J., Miyashita, M., Choi, J. Y., Kang, J., Baik, Y. J., … Lee, H. S. (2011). Measuring comprehensive outcomes in palliative care: Validation of the Korean version of the Good Death Inventory. Journal of Pain and Symptom Management, 42(4), 632–642.
- Shin, D. W., Choi, J. Y., Nam, B. H., Seo, W. S., Kim, H. Y., Hwang, E. J., … Park, E. C. (2010). The current status of utilization of palliative care units in Korea: 6 month results of 2009 Korean Terminal Cancer Patient Information System. Korean Journal of Hospice and Palliative Care, 13(3), 181–189.
- Sizoo, E. M., Taphoorn, M. J., Uitdehaag, B., Heimans, J. J., Deliens, L., Reijneveld, J. C., & Pasman, H. R. (2013). The end-of-life phase of high-grade glioma patients: Dying with dignity? Oncologist, 18(2), 198–203.
- Spiro, S. G., Rudd, R. M., Souhami, R. L., Brown, J., Fairlamb, D. J., Gower, N. H., … West, P. (2004). Chemotherapy versus supportive care in advanced non-small cell lung cancer: Improved survival without detriment to quality of life. Thorax, 59(10), 828–836.
- Stromgren, A. S., Sjogren, P., Goldschmidt, D., Petersen, M. A., Pedersen, L., & Groenvold, M. (2006). Symptom priority and course of symptomatology in specialized palliative care. Journal of Pain and Symptom Management, 31(3), 199–206.
- Stromgren, A. S., Sjogren, P., Goldschmidt, D., Petersen, M. A., Pedersen, L., Hoermann, L., & Groenvold, M. (2005). A longitudinal study of palliative care: Patient-evaluated outcome and impact of attrition. Cancer, 103(8), 1747–1755.
- Tang, S. T., Huang, E. W., Liu, T. W., Wang, H. M., Rau, K. M., & Chen, J. S. (2011). Aggressive end-of-life care significantly influenced propensity for hospice enrollment within the last three days of life for Taiwanese cancer decedents. Journal of Pain and Symptom Management, 41(1), 68–78.
- Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., … Lynch, T. J. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine, 363(8), 733–742.
- Thompson, G. N., & Chochinov, H. M. (2006). Methodological challenges in measuring quality care at the end of life in the long-term care environment. Journal of Pain and Symptom Management, 32(4), 378–391.
- Tzioras, S., Pavlidis, N., Paraskevaidis, E., & Ioannidis, J. P. (2007). Effects of different chemotherapy regimens on survival for advanced cervical cancer: Systematic review and meta-analysis. Cancer Treatment Reviews, 33(1), 24–38.
- Waldron, D., O'Boyle, C. A., Kearney, M., Moriarty, M., & Carney, D. (1999). Quality-of-life measurement in advanced cancer: Assessing the individual. Journal of Clinical Oncology, 17(11), 3603–3611.
- Walsh, D., Donnelly, S., & Rybicki, L. (2000). The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1,000 patients. Supportive Care in Cancer, 8(3), 175–179.
- Wright, A. A., Zhang, B., Ray, A., Mack, J. W., Trice, E., Balboni, T., … Prigerson, H. G. (2008). Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA, 300(14), 1665–1673.
- Yennurajalingam, S., Atkinson, B., Masterson, J., Hui, D., Urbauer, D., Tu, S. M., & Bruera, E. (2012). The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. Journal of Palliative Medicine, 15(1), 20–24.
- Yun, Y. H., Kwon, Y. C., Lee, M. K., Lee, W. J., Jung, K. H., Do, Y. R., … Park, S. Y. (2010). Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. Journal of Clinical Oncology, 28(11), 1950–1957.
